News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
506,887 Results
Type
Article (32921)
Company Profile (52)
Press Release (473910)
Multimedia
Podcasts (107)
Webinars (15)
Section
Business (147634)
Career Advice (1782)
Deals (24839)
Drug Delivery (79)
Drug Development (62027)
Employer Resources (116)
FDA (12043)
Job Trends (10812)
News (250774)
Policy (23485)
Tag
Academia (2196)
Academic (1)
Accelerated approval (11)
Adcomms (20)
Allergies (86)
Alliances (39613)
ALS (118)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (160)
Approvals (12158)
Artificial intelligence (331)
Autoimmune disease (65)
Automation (26)
Bankruptcy (233)
Best Places to Work (8932)
BIOSECURE Act (8)
Biosimilars (99)
Biotechnology (37)
Bladder cancer (116)
Brain cancer (36)
Breast cancer (390)
Cancer (3120)
Cardiovascular disease (276)
Career advice (1510)
Career pathing (30)
CAR-T (168)
CDC (33)
Cell therapy (481)
Cervical cancer (24)
Clinical research (51994)
Collaboration (1102)
Company closure (1)
Compensation (425)
Complete response letters (33)
COVID-19 (1934)
CRISPR (64)
C-suite (399)
Cystic fibrosis (102)
Data (4056)
Decentralized trials (2)
Denatured (35)
Depression (76)
Diabetes (370)
Diagnostics (4789)
Digital health (25)
Diversity (6)
Diversity, equity & inclusion (38)
Drug discovery (156)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (172)
Earnings (65501)
Editorial (37)
Employer branding (14)
Employer resources (101)
Events (76823)
Executive appointments (681)
FDA (14059)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (13)
Funding (874)
Gene editing (129)
Generative AI (33)
Gene therapy (452)
GLP-1 (734)
Government (3433)
Grass and pollen (6)
Guidances (340)
Healthcare (14322)
HIV (36)
Huntington's disease (29)
IgA nephropathy (52)
Immunology and inflammation (146)
Immuno-oncology (9)
Indications (48)
Infectious disease (2109)
Inflammatory bowel disease (133)
Inflation Reduction Act (11)
Influenza (69)
Intellectual property (157)
Interviews (316)
IPO (12450)
IRA (33)
Job creations (2199)
Job search strategy (1257)
Kidney cancer (12)
Labor market (43)
Layoffs (328)
Leadership (29)
Legal (5598)
Liver cancer (56)
Longevity (9)
Lung cancer (446)
Lymphoma (224)
Machine learning (20)
Management (38)
Manufacturing (421)
MASH (143)
Medical device (9676)
Medtech (9694)
Mergers & acquisitions (13158)
Metabolic disorders (901)
Multiple sclerosis (103)
NASH (20)
Neurodegenerative disease (163)
Neuropsychiatric disorders (34)
Neuroscience (2161)
NextGen: Class of 2025 (4799)
Non-profit (3596)
Now hiring (49)
Obesity (392)
Opinion (215)
Ovarian cancer (89)
Pain (141)
Pancreatic cancer (133)
Parkinson's disease (177)
Partnered (21)
Patents (311)
Patient recruitment (247)
Peanut (35)
People (39143)
Pharmaceutical (11)
Pharmacy benefit managers (17)
Phase I (15699)
Phase II (22861)
Phase III (17630)
Pipeline (2395)
Policy (175)
Postmarket research (2201)
Preclinical (7168)
Press Release (41)
Prostate cancer (178)
Psychedelics (30)
Radiopharmaceuticals (218)
Rare diseases (508)
Real estate (3367)
Recruiting (42)
Regulatory (17093)
Reports (29)
Research institute (1851)
Resumes & cover letters (277)
Rett syndrome (15)
RNA editing (10)
RSV (55)
Schizophrenia (112)
Series A (144)
Series B (99)
Service/supplier (4)
Sickle cell disease (59)
Special edition (12)
Spinal muscular atrophy (103)
Sponsored (27)
Startups (2292)
State (1)
Stomach cancer (10)
Supply chain (64)
Tariffs (39)
The Weekly (71)
Vaccines (674)
Venture capital (37)
Weight loss (256)
Women's health (36)
Worklife (14)
Date
Today (39)
Last 7 days (514)
Last 30 days (2016)
Last 365 days (23928)
2025 (19972)
2024 (26868)
2023 (30154)
2022 (38013)
2021 (41136)
2020 (39963)
2019 (34544)
2018 (26021)
2017 (24145)
2016 (23286)
2015 (27347)
2014 (21917)
2013 (18668)
2012 (19081)
2011 (18739)
2010 (17550)
Location
Africa (637)
Alabama (58)
Alaska (4)
Arizona (144)
Arkansas (8)
Asia (28267)
Australia (4997)
California (7025)
Canada (2143)
China (668)
Colorado (294)
Connecticut (326)
Delaware (199)
Europe (65311)
Florida (1106)
Georgia (255)
Idaho (36)
Illinois (552)
India (35)
Indiana (377)
Iowa (10)
Japan (264)
Kansas (92)
Kentucky (20)
Louisiana (14)
Maine (67)
Maryland (951)
Massachusetts (5023)
Michigan (224)
Minnesota (350)
Mississippi (3)
Missouri (69)
Montana (18)
Nebraska (17)
Nevada (83)
New Hampshire (54)
New Jersey (2159)
New Mexico (17)
New York (2035)
North Carolina (1012)
North Dakota (6)
Northern California (3251)
Ohio (226)
Oklahoma (14)
Oregon (27)
Pennsylvania (1542)
Puerto Rico (9)
Rhode Island (28)
South America (887)
South Carolina (31)
South Dakota (1)
Southern California (2793)
Tennessee (125)
Texas (1145)
United States (25998)
Utah (221)
Virginia (176)
Washington D.C. (59)
Washington State (620)
West Virginia (2)
Wisconsin (56)
Wyoming (2)
506,887 Results for "crg and associates llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock - May 14, 2024
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced that entities affiliated with CRG Servicing LLC have converted Series A and Series B Convertible Preferred Stock to Common Stock.
May 14, 2024
·
4 min read
Genetown
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc. announced the entrance into a definitive agreement to convert $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity upon stockholder approval.
February 15, 2024
·
5 min read
Genetown
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of an additional $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity.
May 6, 2024
·
4 min read
Press Releases
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
October 21, 2025
·
3 min read
Biotech Bay
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
Avinger, Inc. announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. into a shares of a new series of convertible preferred stock.
May 16, 2024
·
3 min read
Press Releases
Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
August 26, 2025
·
2 min read
Press Releases
Praxis Packaging Solutions Expands with Acquisition of Advanced Concept Innovations, LLC
September 25, 2025
·
1 min read
Press Releases
Denovo Biopharma LLC to Participate in Upcoming Investor Events
August 15, 2025
·
1 min read
Genetown
T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems common stock and Series B convertible preferred stock.
July 6, 2023
·
4 min read
Press Releases
NorthStar Medical Radioisotopes, LLC and University of Wisconsin School of Medicine and Public Health Enter Strategic Partnership to Advance Radiopharmaceutical Research, Innovation and Talent Development
September 24, 2025
·
4 min read
1 of 50,689
Next
